An by AARP reveals the manufacturers of many top-selling biologic drugs have recouped average costs several times over in the past 6 years. (link)
Posted by
mara
May 30 '09, 09:27
|
A new analysis by AARP�s Public Policy Institute reveals the manufacturers of many top-selling biologic drugs have recouped average research and development costs several times over in the past six years, often within a single year. The report�s finding busts the myth that allowing generic versions of biologic drugs will undermine further development of these breakthrough medicines.
|